AB Bernstein
Lee Hambright is a seasoned professional in the medical devices sector, currently serving as a Senior Research Analyst at AB Bernstein since April 2017. Prior experience includes holding the position of VP Corporate Development at Waters Corporation from March 2016 to April 2017, and serving as Chief Commercial Officer at PatientPoint® between October 2013 and February 2016. Lee has also held significant roles at Medtronic, including VP of Business Development & Strategy for Medtronic Spinal and VP of Strategy & Alliance for Biologics, from February 2009 to October 2013. Earlier in the career, Lee worked as a Management Consultant at McKinsey & Company from August 1998 to January 2009. Educational qualifications include an MBA from Harvard Business School and a BBA in Accounting & Philosophy from the University of Notre Dame.
This person is not in the org chart
AB Bernstein
Bernstein is widely recognized as Wall Street's premier sell-side research and brokerage firm, with a global equity trading platform that spans the U.S., Europe, and Asia. Our firm was founded in the U.S. in 1967 and in the U.K. in 1999. Our research and trading capabilities are sought out by leading investment managers around the world, and we are annually ranked at the top of our industry by acknowledged arbiters. In independent surveys of major institutional clients, Bernstein's research is ranked #1 for overall quality, industry knowledge, most trusted, best detailed financial analysis, major company studies, most useful valuation frameworks and best original research. In Institutional Investor’s latest annual client survey, the leading survey by which research analysts in our industry are evaluated, over 90% of our U.S. analysts and the majority of our European Analysts were recognized as among the best in their respective fields – more than any other firm in our industry. We began operations in Hong Kong in 2010, and now cover a range of sectors across Asia. Our European research team is also home to Extel's #1-ranked analyst across Europe. In April 2019 we acquired Autonomous Research, a highly regarded global financial services independent research firm. The combination of Bernstein and Autonomous solidifies our standing as the largest global independent research firm. Research has always been Bernstein's calling card. The brand is defined by our renowned Blackbooks, known for their unbiased, in-depth company and industry forecasts. We have a community of Research Analysts who are acknowledged thought leaders that typically have many years of experience in the industries they cover. Our reputation is for the very highest caliber of independent and disciplined investment and industry analysis. We are a wholly-owned subsidiary of our buy-side parent, AB.